SCHEMBL16348997

SCHEMBL16348997

COc1cccc(-c2cnc(Nc3ccc(N4CCNCC4)cc3)o2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCP P55072 2/20 0.66
ACVR1 Q04771 3/20 0.54
TGFBR1 P36897 3/20 0.54
IMPDH2 P12268 1/20 0.53
ACVRL1 P37023 1/20 0.52
KDR P35968 4/20 0.51
FLT1 P17948 3/20 0.51
FLT4 P35916 3/20 0.51
HTR1A P08908 2/20 0.50
HTR7 P34969 2/20 0.50
HTR2B P41595 2/20 0.50
HTR3A P46098 2/20 0.50
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
HTR6 P50406 1/20 0.50
ADRB1 P08588 1/20 0.50
MAPKAPK2 P49137 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP1A1 P04798 1/20 0.47
CYP1B1 Q16678 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5470454 0.91 VCP (0.69) VCPIMPDH2KDRFLT1FLT4
SCHEMBL16349075 0.90 VCP (0.53) VCPACVR1TGFBR1IMPDH2ACVRL1
SCHEMBL5469457 0.90 VCP (0.68) VCPIMPDH2KDRFLT1FLT4
SCHEMBL16349171 0.89 ACVR1 (0.56) VCPACVR1TGFBR1IMPDH2ACVRL1
SCHEMBL5472158 0.89 VCP (0.67) VCPIMPDH2KDRFLT1FLT4
SCHEMBL16348972 0.89 VCP (0.51) VCPACVR1TGFBR1IMPDH2ACVRL1
SCHEMBL16349128 0.88 VCP (0.60) VCPACVR1TGFBR1IMPDH2ACVRL1
SCHEMBL16349076 0.88 VCP (0.50) VCPACVR1TGFBR1IMPDH2ACVRL1
SCHEMBL16349121 0.88 VCP (0.50) VCPACVR1TGFBR1IMPDH2ACVRL1
SCHEMBL16348973 0.87 VCP (0.59) VCPACVR1TGFBR1IMPDH2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189712-B2 1,3-Oxazole compounds for the treatment of cancer SMITHKLINE BEECHAM CORPORATION (US) 2007-03-13 US disclosed